NO20054532L - Fremgangsmater for a forhindre glukonoylering av proteiner - Google Patents

Fremgangsmater for a forhindre glukonoylering av proteiner

Info

Publication number
NO20054532L
NO20054532L NO20054532A NO20054532A NO20054532L NO 20054532 L NO20054532 L NO 20054532L NO 20054532 A NO20054532 A NO 20054532A NO 20054532 A NO20054532 A NO 20054532A NO 20054532 L NO20054532 L NO 20054532L
Authority
NO
Norway
Prior art keywords
preventing
gluconeylation
proteins
methods
gluconylation
Prior art date
Application number
NO20054532A
Other languages
English (en)
Norwegian (no)
Other versions
NO20054532D0 (no
Inventor
Alan Gardner
Thomasd Sweitzer
Alexander H Taylor
P Patel
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20054532D0 publication Critical patent/NO20054532D0/no
Publication of NO20054532L publication Critical patent/NO20054532L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Enzymes And Modification Thereof (AREA)
NO20054532A 2003-03-04 2005-10-03 Fremgangsmater for a forhindre glukonoylering av proteiner NO20054532L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45168603P 2003-03-04 2003-03-04
PCT/US2004/006507 WO2004078936A2 (fr) 2003-03-04 2004-03-04 Procedes permettant d'empecher la glyconoylation de proteines

Publications (2)

Publication Number Publication Date
NO20054532D0 NO20054532D0 (no) 2005-10-03
NO20054532L true NO20054532L (no) 2005-11-24

Family

ID=32962626

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054532A NO20054532L (no) 2003-03-04 2005-10-03 Fremgangsmater for a forhindre glukonoylering av proteiner

Country Status (21)

Country Link
US (2) US8173396B2 (fr)
EP (1) EP1599578B1 (fr)
JP (1) JP2006520609A (fr)
KR (2) KR101146483B1 (fr)
CN (2) CN1798836B (fr)
AR (1) AR043719A1 (fr)
AT (1) ATE517985T1 (fr)
AU (2) AU2004217491B2 (fr)
BR (1) BRPI0408023A (fr)
CA (1) CA2517857A1 (fr)
ES (1) ES2369359T3 (fr)
IS (1) IS8029A (fr)
MA (1) MA27744A1 (fr)
MX (1) MXPA05009453A (fr)
MY (1) MY142798A (fr)
NO (1) NO20054532L (fr)
NZ (1) NZ570598A (fr)
RU (2) RU2005130650A (fr)
TW (1) TW200504218A (fr)
WO (1) WO2004078936A2 (fr)
ZA (1) ZA200506709B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2542391A (en) 2015-09-17 2017-03-22 Annexin Pharmaceuticals Ab Process of manufacture
JP7304380B2 (ja) 2021-04-26 2023-07-06 プライムプラネットエナジー＆ソリューションズ株式会社 電極集電体および二次電池
WO2025252176A1 (fr) * 2024-06-05 2025-12-11 杭州明德生物医药技术有限公司 Vecteur d'expression et utilisation associée

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643758A (en) * 1987-03-10 1997-07-01 New England Biolabs, Inc. Production and purification of a protein fused to a binding protein
ATE135403T1 (de) * 1987-03-10 1996-03-15 New England Biolabs Inc Herstellung und reinigung eines proteins, das mit einem bindungsprotein fusioniert ist
DE4028086A1 (de) * 1990-09-05 1992-03-12 Boehringer Mannheim Gmbh Stabile 6-phosphogluconolactonase, verfahren zu deren gewinnung sowie verwendung des enzyms zur bestimmung
US5733762A (en) * 1994-04-28 1998-03-31 I.D.M. Immuno-Designed Molecules Complexes of nucleic acid and polymer, their process of preparation and their use for the transfection of cells
US5948681A (en) * 1996-08-14 1999-09-07 Children's Hospital Of Philadelphia Non-viral vehicles for use in gene transfer

Also Published As

Publication number Publication date
AU2004217491A1 (en) 2004-09-16
AU2004217491B2 (en) 2009-04-09
KR20110134514A (ko) 2011-12-14
IS8029A (is) 2005-09-15
AR043719A1 (es) 2005-08-10
CA2517857A1 (fr) 2004-09-16
ZA200506709B (en) 2006-08-30
US20120196372A1 (en) 2012-08-02
BRPI0408023A (pt) 2006-02-14
WO2004078936A3 (fr) 2006-02-16
EP1599578B1 (fr) 2011-07-27
AU2009201136A1 (en) 2009-04-09
CN1798836A (zh) 2006-07-05
CN101942470A (zh) 2011-01-12
US20090233333A1 (en) 2009-09-17
TW200504218A (en) 2005-02-01
CN1798836B (zh) 2011-04-27
EP1599578A4 (fr) 2007-03-14
KR101146483B1 (ko) 2012-05-24
MA27744A1 (fr) 2006-02-01
ES2369359T3 (es) 2011-11-29
NO20054532D0 (no) 2005-10-03
AU2009201136B2 (en) 2011-06-23
MXPA05009453A (es) 2005-11-23
KR20050107486A (ko) 2005-11-11
MY142798A (en) 2010-12-31
RU2005130650A (ru) 2006-04-10
EP1599578A2 (fr) 2005-11-30
ATE517985T1 (de) 2011-08-15
WO2004078936A2 (fr) 2004-09-16
NZ570598A (en) 2010-03-26
JP2006520609A (ja) 2006-09-14
US8173396B2 (en) 2012-05-08
RU2009149159A (ru) 2011-07-10

Similar Documents

Publication Publication Date Title
DE60132978D1 (de) Hybride expression von neisseria proteinen
NO20091976L (no) Nye forbindelser
NO20071378L (no) Tiazolo-naftylsyrer.
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
BRPI0414599A (pt) pirrol-indóis substituìdos
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
ATE433973T1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
NO20062860L (no) Sammensetning og fremgangsmate for styrking av biologisk tilgjengelighet
ATE417051T1 (de) Polymorphe von clopidogrel-hydrogensulfat
DE602004024572D1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
BRPI0409367A (pt) derivados de piperidina inibidores de renina
DE602004030334D1 (de) Synthese von 5-substituierten 7-azaindolen und 7-azaindolinen
SI1644484T1 (sl) Avtologne samo-toleranco inducirajoče celice monocitnega izvora in njihova uporaba v farmacevtskihpripravah
DE602004024181D1 (de) Verfahren zur gewinnung von gallium-68 und dessen verwendung und hilfsmittel zur durchführung dieses verfahrens
BRPI0414463A (pt) ácidos heteroarilbenzofuránicos substituìdos
DE10390418D2 (de) Verfahren zur Herstellung von rekombinanten Proteinen in Mikroorganismen
MY138542A (en) Biguanide and dihydrotriazine derivatives
NO20055741D0 (no) Nye kjemiske forbindelser
EA200701293A1 (ru) Терапевтическая композиция фактора роста кератиноцитов
DE60322727D1 (de) Rückgefaltetes Membranprotein in monodisperser Form
MXPA04005079A (es) Variantes del dominio c2 del factor viii.
ATE486931T1 (de) Hybridpolymerase-verfahren und -zusammensetzungen
NO20050599L (no) Fremgangsmate for a anrike og spore patologisk modifiserte prion-proteiner (PRPsc)
DE602004019541D1 (de) Cycloalkyläbü kondensierte indole

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application